Molecular Insights Into the Relationship Between Autoimmune Thyroid Diseases and Breast Cancer: A Critical Perspective on Autoimmunity and ER Stress.
Grave's disease
Hashimotos's thyroiditis
autoantibodies
autoantigens
lymphocytic infiltration
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
11
11
2018
accepted:
11
02
2019
entrez:
19
3
2019
pubmed:
19
3
2019
medline:
18
9
2020
Statut:
epublish
Résumé
The etiopathologies behind autoimmune thyroid diseases (AITDs) unravel misbehavior of immune components leading to the corruption of immune homeostasis where thyroid autoantigens turn foe to the self. In AITDs lymphocytic infiltration in the thyroid shows up a deranged immune system charging the follicular cells of the thyroid gland (thyrocytes) leading to the condition of either hyperthyroidism or hypothyroidism. The inflammation in AITDs consistently associate with ER function due to which disturbances in the ER protein homeostasis leads to unfolded protein response (UPR) that promotes pathogenesis of autoimmunity. The roles of ER stress in the instantaneous downregulation of MHC class I molecules on thyrocytes and the relevance of IFN γ in the pathogenesis of AITD has been well-documented. Thyroglobulin being the major target of autoantibodies in most of the AITDs is because of its unusual processing in the ER. Autoimmune disorders display a conglomeration of ER stress-induced UPR activated molecules. Several epidemiological data highlight the preponderance of AITDs in women as well as its concurrence with breast cancer. Both being an active glandular system displaying endocrine activity, thyroid as well as breast tissue show various commonalities in the expression pattern of heterogenous molecules that not only participate in the normal functioning but at the same time share the blame during disease establishment. Studies on the development and progression of breast carcinoma display a deranged and uncontrolled immune response, which is meticulously exploited during tumor metastasis. The molecular crosstalks between AITDs and breast tumor microenvironment rely on active participation of immune cells. The induction of ER stress by Tunicamycin advocates to provide a model for cancer therapy by intervening glycosylation. Therefore, this review attempts to showcase the molecules that are involved in feeding up the relationship between breast carcinoma and AITDs.
Identifiants
pubmed: 30881358
doi: 10.3389/fimmu.2019.00344
pmc: PMC6405522
doi:
Substances chimiques
Autoantigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
344Références
Br J Cancer. 1993 Jul;68(1):122-4
pubmed: 7686390
Front Aging Neurosci. 2018 Feb 06;10:30
pubmed: 29467648
Endocr Relat Cancer. 2001 Sep;8(3):197-209
pubmed: 11566611
Endocrinology. 2014 Feb;155(2):627-34
pubmed: 24302624
Front Endocrinol (Lausanne). 2017 Sep 29;8:262
pubmed: 29033899
EMBO Mol Med. 2016 Jul 01;8(7):729-44
pubmed: 27226027
BMC Immunol. 2009 Feb 16;10:10
pubmed: 19220912
Horm Res. 2003;59(3):118-24
pubmed: 12637791
J Clin Invest. 2007 Feb;117(2):448-56
pubmed: 17273557
Oncotarget. 2017 Feb 21;8(8):13703-13715
pubmed: 28099147
Clin Endocrinol (Oxf). 1989 Dec;31(6):655-65
pubmed: 2627756
Nature. 2006 May 11;441(7090):235-8
pubmed: 16648838
Biochim Biophys Acta. 2011 Apr;1812(4):431-8
pubmed: 21199669
J Autoimmune Dis. 2005 Mar 11;2(1):1
pubmed: 15762980
J Natl Cancer Inst. 2000 Aug 16;92(16):1329-36
pubmed: 10944555
J Immunol. 2003 Jun 15;170(12):6348-54
pubmed: 12794168
Curr Genomics. 2011 Dec;12(8):576-88
pubmed: 22654557
Clin Cancer Res. 2004 Jul 1;10(13):4294-302
pubmed: 15240514
Cell. 2000 Apr 28;101(3):249-58
pubmed: 10847680
Mol Cell Biol. 2011 Sep;31(17):3616-29
pubmed: 21709020
Am J Pathol. 2008 Sep;173(3):600-9
pubmed: 18688037
J Immunol. 2009 Mar 1;182(5):2708-16
pubmed: 19234165
Cancer Res. 2012 Nov 1;72(21):5505-15
pubmed: 22962269
Autoimmunity. 2003 Sep-Nov;36(6-7):423-8
pubmed: 14669951
J Clin Invest. 2005 Aug;115(8):1972-83
pubmed: 16075037
N Engl J Med. 2016 Oct 20;375(16):1552-1565
pubmed: 27797318
Endocrinology. 2009 Mar;150(3):1084-90
pubmed: 19196800
J Biol Chem. 2001 Jul 13;276(28):26699-707
pubmed: 11323435
J Clin Endocrinol Metab. 2015 Mar;100(3):1071-7
pubmed: 25485727
Int J Cancer. 2000 Aug 1;87(3):349-59
pubmed: 10897039
Immunol Res. 2012 Dec;54(1-3):204-13
pubmed: 22457094
J Immunol. 2007 Mar 1;178(5):3281-7
pubmed: 17312178
Annu Rev Immunol. 1999;17:189-220
pubmed: 10358757
Glycobiology. 2018 Feb 1;28(2):61-68
pubmed: 29206917
Biomed Pharmacother. 2016 Feb;77:161-6
pubmed: 26796280
Nat Immunol. 2005 Nov;6(11):1133-41
pubmed: 16200068
Front Immunol. 2017 Apr 07;8:396
pubmed: 28439272
J Endocrinol Invest. 2004 Oct;27(9):862-5
pubmed: 15648551
Breast Cancer Res. 2007;9(1):301
pubmed: 17274833
J Clin Endocrinol Metab. 1998 Apr;83(4):1217-21
pubmed: 9543144
Cell Mol Immunol. 2007 Feb;4(1):1-13
pubmed: 17349207
Thyroid. 2002 Oct;12(10):839-47
pubmed: 12487765
Oncol Rep. 2007 Dec;18(6):1603-11
pubmed: 17982651
J Clin Invest. 2012 Sep;122(9):3035-43
pubmed: 22945636
J Clin Endocrinol Metab. 2000 May;85(5):2020-7
pubmed: 10843191
J Clin Invest. 2015 Jun;125(6):2228-33
pubmed: 25893595
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6561-6
pubmed: 21464300
Br J Cancer. 1998;77(1):51-6
pubmed: 9459145
Clin Cancer Res. 2005 Apr 15;11(8):2962-8
pubmed: 15837748
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
J Clin Invest. 2002 Dec;110(11):1667-74
pubmed: 12464672
Nat Rev Immunol. 2008 Jan;8(1):34-47
pubmed: 18064051
Nat Immunol. 2005 Apr;6(4):345-52
pubmed: 15785760
J Clin Endocrinol Metab. 1996 Mar;81(3):990-4
pubmed: 8772562
J Clin Endocrinol Metab. 1984 Oct;59(4):734-8
pubmed: 6548225
Immunogenetics. 2002 Jun;54(3):141-57
pubmed: 12073143
PLoS One. 2012;7(12):e51845
pubmed: 23272178
J Clin Endocrinol Metab. 1998 Aug;83(8):2711-6
pubmed: 9709936
Thyroid Res. 2018 Feb 13;11:2
pubmed: 29449887
Endocr Relat Cancer. 2006 Sep;13(3):797-826
pubmed: 16954431
Eur J Endocrinol. 1995 Apr;132(4):399-405
pubmed: 7711875
J Biol Chem. 1996 Feb 23;271(8):4545-52
pubmed: 8626810
Mol Cell Biol. 2003 Nov;23(21):7448-59
pubmed: 14559994
J Burn Care Res. 2010 Jan-Feb;31(1):158-75
pubmed: 20061852
J Interferon Cytokine Res. 2015 Jan;35(1):1-16
pubmed: 25068787
J Clin Invest. 2016 Apr 1;126(4):1525-37
pubmed: 26999605
Int J Cancer. 2014 Apr 1;134(7):1706-14
pubmed: 24114667
Autoimmunity. 1997;25(2):91-6
pubmed: 9189010
J Clin Invest. 2001 Nov;108(9):1253-9
pubmed: 11696565
PeerJ. 2017 Jan 10;5:e2815
pubmed: 28097051
Clin Exp Immunol. 2003 May;132(2):193-200
pubmed: 12699405
J Clin Endocrinol Metab. 2003 Apr;88(4):1880-8
pubmed: 12679487
Endocrinol Nutr. 2016 Oct;63(8):421-9
pubmed: 27234136
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8374-8
pubmed: 8710878
Clin Endocrinol (Oxf). 2000 Mar;52(3):267-71
pubmed: 10718823
J Immunol. 2008 Sep 15;181(6):4397-405
pubmed: 18768899
Breast Cancer Res Treat. 1995 Mar;33(3):209-17
pubmed: 7749148
Clin Immunol Immunopathol. 1986 Nov;41(2):165-74
pubmed: 3533331
Curr Opin Immunol. 2011 Feb;23(1):35-40
pubmed: 21094031
Nat Immunol. 2000 Dec;1(6):483-8
pubmed: 11101869
Presse Med. 2012 Dec;41(12 P 2):e611-25
pubmed: 23164679
J Clin Endocrinol Metab. 2005 Apr;90(4):2321-6
pubmed: 15623812
Nat Commun. 2018 Jan 24;9(1):353
pubmed: 29367624
N Engl J Med. 1996 Jul 11;335(2):99-107
pubmed: 8649497
Tissue Antigens. 2012 Nov;80(5):431-6
pubmed: 23020308
Lancet. 1975 Dec 6;2(7945):1119-21
pubmed: 53602
Clin Exp Immunol. 1997 Dec;110(3):434-9
pubmed: 9409648
Int J Cancer. 2008 Jul 1;123(1):85-8
pubmed: 18386815
Endocr Rev. 2003 Feb;24(1):48-77
pubmed: 12588808
NPJ Precis Oncol. 2017;1:
pubmed: 29152592
J Clin Endocrinol Metab. 2001 Feb;86(2):930-4
pubmed: 11158069
Ann N Y Acad Sci. 2002 Jun;966:496-501
pubmed: 12114310
Thyroid. 2002 Dec;12(12):1043-50
pubmed: 12593717
J Clin Endocrinol Metab. 1996 Mar;81(3):937-41
pubmed: 8772554
J Biol Chem. 1999 Aug 13;274(33):23627-32
pubmed: 10438545
Cell. 2001 Dec 28;107(7):881-91
pubmed: 11779464
J Immunol. 2001 Dec 1;167(11):6678-86
pubmed: 11714840
Autoimmun Rev. 2016 Apr;15(4):379-92
pubmed: 26774011
Endocrinology. 2004 Dec;145(12):5504-14
pubmed: 15331574
Curr Opin Immunol. 2016 Dec;43:60-66
pubmed: 27718448
Cancer Res. 2002 Feb 15;62(4):1093-102
pubmed: 11861388
Am J Pathol. 2012 Mar;180(3):1059-1067
pubmed: 22214837
Genes Immun. 2008 Mar;9(2):182-6
pubmed: 18094708
Autoimmunity. 1992;11(4):239-46
pubmed: 1581468
Curr Opin Immunol. 2016 Apr;39:44-51
pubmed: 26796069
J Immunol. 2001 Feb 1;166(3):1492-8
pubmed: 11160188
Eur J Cancer. 2016 Nov;67:1-10
pubmed: 27591414
Immunity. 2015 Jun 16;42(6):1185-96
pubmed: 26084028
J Clin Endocrinol Metab. 1998 Apr;83(4):1222-5
pubmed: 9543145
Annu Rev Immunol. 1990;8:401-20
pubmed: 2188668
J Clin Invest. 2003 Jun;111(12):1897-904
pubmed: 12813025
Autoimmun Rev. 2015 Feb;14(2):174-80
pubmed: 25461470
Autoimmunity. 1995;20(4):231-6
pubmed: 7578885
Int J Immunogenet. 2009 Apr;36(2):85-96
pubmed: 19284442
J Exp Med. 1997 Dec 15;186(12):2045-50
pubmed: 9396774
Clin Exp Immunol. 1995 Nov;102(2):328-34
pubmed: 7586686
Thyroid. 1997 Dec;7(6):843-6
pubmed: 9459626
Nat Med. 2000 Aug;6(8):871-8
pubmed: 10932223
J Clin Invest. 2014 Nov;124(11):4678-80
pubmed: 25365074
Immunol Lett. 2001 Oct 1;78(3):123-6
pubmed: 11578685
J Clin Endocrinol Metab. 2015 Jan;100(1):E1-10
pubmed: 25295624
Pharmacol Ther. 2012 Sep;135(3):355-70
pubmed: 22750642
J Immunol. 2008 Oct 15;181(8):5768-74
pubmed: 18832736
Arthritis Rheum. 2010 Aug;62(8):2239-48
pubmed: 20506563
Endocr Rev. 2003 Dec;24(6):802-35
pubmed: 14671007
J Immunol. 1999 Jan 1;162(1):263-7
pubmed: 9886394
J Clin Endocrinol Metab. 2009 Jul;94(7):2626-33
pubmed: 19351722
In Vitro Cell Dev Biol Anim. 1993 Dec;29A(12):936-42
pubmed: 8167917
Mayo Clin Proc. 1976 May;51(5):263-5
pubmed: 946676
Endokrynol Pol. 2010 Jan-Feb;61(1):112-6
pubmed: 20205113
Front Immunol. 2017 May 09;8:521
pubmed: 28536577
Pharmacol Rev. 2010 Jun;62(2):199-236
pubmed: 20392809
Am Fam Physician. 2001 Nov 15;64(10):1717-24
pubmed: 11759078
Cancer Res. 2015 Dec 15;75(24):5367-77
pubmed: 26573792
J Clin Endocrinol Metab. 1996 Oct;81(10):3622-8
pubmed: 8855812
Crit Rev Immunol. 1997;17(5-6):463-8
pubmed: 9419433
J Am Soc Nephrol. 2017 Jul;28(7):1973-1982
pubmed: 28465380
Mol Med. 2012 Feb 10;18:123-37
pubmed: 22033729
Breast Cancer Res Treat. 2004 Mar;84(1):49-60
pubmed: 14999154
Acta Med Scand. 1986;219(1):105-11
pubmed: 3754083
Saudi Pharm J. 2019 Mar;27(3):437-445
pubmed: 30976189
Immunol Today. 1997 Sep;18(9):437-42
pubmed: 9293160
Science. 1997 Feb 14;275(5302):960-3
pubmed: 9020075
Eur J Immunol. 2009 Sep;39(9):2403-11
pubmed: 19670381
N Engl J Med. 2000 Oct 26;343(17):1236-48
pubmed: 11071676
Annu Rev Immunol. 2009;27:485-517
pubmed: 19132915
Oncogenesis. 2017 Aug 28;6(8):e373
pubmed: 28846078
Nat Commun. 2018 Aug 15;9(1):3267
pubmed: 30111846
Endocr Rev. 2014 Feb;35(1):59-105
pubmed: 24091783
Annu Rev Immunol. 2015;33:107-38
pubmed: 25493331
Cent Eur J Immunol. 2015;40(4):470-6
pubmed: 26862312
Clin Immunol. 2013 Dec;149(3):411-20
pubmed: 24211715
J Pediatr Endocrinol Metab. 2014 Nov;27(11-12):1257-60
pubmed: 24945421
J Immunol. 2002 Jan 15;168(2):942-50
pubmed: 11777993
Clin Endocrinol (Oxf). 2001 Jul;55(1):1-11
pubmed: 11453945
Eur J Cancer. 2002 Nov;38(17):2252-7
pubmed: 12441261
Lancet. 1983 Nov 12;2(8359):1115-9
pubmed: 6138647
PLoS Med. 2006 Aug;3(8):e297
pubmed: 16942393
J Immunol. 2008 Jul 1;181(1):795-807
pubmed: 18566446
Front Endocrinol (Lausanne). 2015 Apr 24;6:59
pubmed: 25964777
PLoS One. 2013 Jun 27;8(6):e67349
pubmed: 23826274
Endocrine. 2016 Apr;52(1):30-8
pubmed: 26475497
J Clin Endocrinol Metab. 1986 Apr;62(4):723-8
pubmed: 3081570
J Cell Biol. 2001 May 28;153(5):1011-22
pubmed: 11381086
Cell Immunol. 2018 Nov;333:46-57
pubmed: 29576316
Nat Immunol. 2018 Feb;19(2):108-119
pubmed: 29348500
J Clin Invest. 2002 Jul;110(2):209-17
pubmed: 12122113
J Clin Endocrinol Metab. 1986 Feb;62(2):357-67
pubmed: 2416769
Cell Prolif. 1994 Feb;27(2):63-71
pubmed: 10465027
Biomedicines. 2018 Feb 11;6(1):
pubmed: 29439457
Br J Cancer. 2013 Mar 5;108(4):914-23
pubmed: 23385730
Front Aging Neurosci. 2017 Oct 24;9:341
pubmed: 29114219
Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):59-66
pubmed: 22507318
Am J Hum Genet. 2003 Oct;73(4):736-47
pubmed: 12973666
Exp Mol Med. 2017 Nov 10;49(11):e389
pubmed: 29123254
PLoS One. 2015 May 27;10(5):e0127949
pubmed: 26016954
Thyroid. 2009 May;19(5):495-501
pubmed: 19415997
Nature. 2014 Apr 3;508(7494):103-107
pubmed: 24670641
Clin Endocrinol (Oxf). 1979 Jul;11(1):59-68
pubmed: 391444
J Clin Endocrinol Metab. 1988 Feb;66(2):367-75
pubmed: 3276724
Front Neuroendocrinol. 2014 Aug;35(3):347-69
pubmed: 24793874
Clin Exp Immunol. 2005 Feb;139(2):216-24
pubmed: 15654820
Immunol Invest. 2018 Apr;47(3):279-292
pubmed: 29319368
Int J Mol Sci. 2014 Nov 25;15(12):21674-86
pubmed: 25429429
J Pathol. 1995 Dec;177(4):369-76
pubmed: 8568591
Immunology. 2000 Feb;99(2):320-5
pubmed: 10692053
Biochem Biophys Res Commun. 1989 Dec 29;165(3):1250-5
pubmed: 2610690
Oncoimmunology. 2012 Oct 1;1(7):1104-1110
pubmed: 23170258
Annu Rev Immunol. 1996;14:397-440
pubmed: 8717520
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15005-9
pubmed: 18815375
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
pubmed: 17565364
World J Immunol. 2014 Mar 27;4(1):26-33
pubmed: 25621222
J Clin Endocrinol Metab. 2011 Dec;96(12):3827-37
pubmed: 21956421
Arthritis Rheum. 2001 Apr;44(4):761-71
pubmed: 11315915
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15119-24
pubmed: 14657345
Front Immunol. 2018 Jun 06;9:1289
pubmed: 29928282
Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):409-14
pubmed: 25105999
J Clin Endocrinol Metab. 1994 Nov;79(5):1232-3
pubmed: 7962313
Eur J Endocrinol. 2004 Mar;150(3):363-9
pubmed: 15012623
Annu Rev Immunol. 2004;22:531-62
pubmed: 15032588
Breast Cancer Res. 2003;5(5):R110-3
pubmed: 12927040
EMBO J. 2013 Sep 11;32(18):2477-90
pubmed: 23942232
PLoS One. 2015 Apr 16;10(4):e0123938
pubmed: 25880730
Hormones (Athens). 2002 Jan-Mar;1(1):35-41
pubmed: 17018436
J Korean Med Sci. 2014 Jan;29(1):2-11
pubmed: 24431899
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3725-30
pubmed: 21321210
Thyroid. 2013 Jul;23(7):879-84
pubmed: 23421548
Cancer Res. 2011 Oct 1;71(19):6153-64
pubmed: 21844185
Mol Cell. 2000 May;5(5):897-904
pubmed: 10882126
Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):291-302
pubmed: 22632366
Diabetes. 2012 Apr;61(4):818-27
pubmed: 22442300
Endocr J. 2004 Aug;51(4):399-405
pubmed: 15351796
Nature. 1998 Aug 27;394(6696):897-901
pubmed: 9732873
ISRN Endocrinol. 2013 Jun 26;2013:509764
pubmed: 23878745
Int Immunol. 2015 Oct;27(10):495-504
pubmed: 25957264
Clin Exp Immunol. 2013 Jan;171(1):63-8
pubmed: 23199324